Delivery Order SPE2DB25D3404-SPE2DB25FUPSH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,673.10 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency awarded a $3,914.81 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at approximately $13,969 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,151.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit dose packages) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used to treat chronic...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $13,509.57 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,262.72 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency awarded a $40,852.26 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of July 24, 2025, with performance to take place at the vendor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used primarily in the treatment of chronic hepatitis B, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,293.43 to AmerisourceBergen Drug Corp for 30 tablets of Vemlidy 25 mg on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPSHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,617.18 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through its federal contracts. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor agreement enables the contractor to supply a wide range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and recurring federal medical procurement vendor demonstrates its established capability to meet DLA's ongoing pharmaceutical supply requirements through competitive delivery orders like this Vemlidy procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/8/25 |